Physician

Brian E Daikh, MD

According to 2025 Medicare claims, Brian Daikh, MD (NPI: 1184617953) practices rheumatology in the Portland-South Portland, ME market, with the plurality of this provider's patient population coming from Cumberland, ME. This provider's primary affiliated billing organization is RHEUMATOLOGY ASSOCIATES P.A. (NPI: 1003098252; TIN: 010321993) and primary practice location at 04102-2643. Daikh is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290) and Community Care Partnership of Maine, LLC (ACO ID: A2831), participating under the MSSP model.

Daikh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 500 traditional Medicare patients, billed 128,272 HCPCS/CPT codes, and received $1,575,470 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,171 prescription claims across 841 beneficiaries totaling $5,905,489 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 1 records totaling $13. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,108,848 to $5,905,489. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	709	48,707	$1,368,246
2016	748	57,256	$1,579,258
2017	703	68,705	$1,770,941
2018	720	86,171	$2,081,713
2019	643	100,963	$1,979,909
2020	586	95,476	$2,020,633
2021	524	85,432	$1,808,756
2022	514	90,207	$1,559,664
2023	510	102,034	$1,517,138
2024	500	128,272	$1,575,470

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	590	3,928	$1,108,848
2016	622	4,450	$1,627,552
2017	638	4,393	$1,911,252
2018	710	4,490	$2,102,253
2019	681	4,373	$2,435,534
2020	693	4,350	$3,049,254
2021	725	4,605	$3,960,245
2022	704	4,247	$4,437,393
2023	731	4,355	$4,789,000
2024	841	5,171	$5,905,489

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	289	515	$89
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	357	561	$12
80053	Blood test, comprehensive group of blood chemicals	190	522	$10
36415	Insertion of needle into vein for collection of blood sample	291	702	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	206	533	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	137	4,284	$1,131,380
Enbrel Sureclick	Etanercept	118	4,032	$1,051,701
Rinvoq	Upadacitinib	87	2,730	$583,722
Xeljanz Xr	Tofacitinib Citrate	91	2,910	$545,864
Enbrel	Etanercept	59	1,904	$394,141

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$13	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian E. Daikh, MD?

Tedicare shows public-source Medicare data for Brian E. Daikh, MD (NPI 1184617953), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian E. Daikh, MD have ACO affiliation data?

Brian E. Daikh, MD is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290) and Community Care Partnership of Maine, LLC (MSSP, ACO ID A2831).

What billing organization is linked to Brian E. Daikh, MD?

Brian E. Daikh, MD is linked to RHEUMATOLOGY ASSOCIATES P.A. (billing NPI 1003098252) in the available physician profile data.

Does Brian E. Daikh, MD have Open Payments data?

Brian E. Daikh, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.